1.0Carine Nsiona & Avocatshttps://www.cnavocats.com/en/M&A | Carine Nsiona & Avocatsrich600338<blockquote class="wp-embedded-content" data-secret="Klk1OvYWmx"><a href="https://www.cnavocats.com/en/ma-2/">M&A</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://www.cnavocats.com/en/ma-2/embed/#?secret=Klk1OvYWmx" width="600" height="338" title="“M&A” — Carine Nsiona & Avocats" data-secret="Klk1OvYWmx" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript">
/* <![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://www.cnavocats.com/wp-includes/js/wp-embed.min.js
/* ]]> */
</script>
Setting up and structuring the company sale process for a Swiss company group with substantial operations in Austria and active in the European and international biotechnology market in connection with the sale of its entire business to an Austrian group of investors (value of the transaction: €70 million).